Literature DB >> 11210860

Steroid-dependent anosmia.

M H Stevens1.   

Abstract

OBJECTIVE: To document the response to steroids in patients remaining anosmic following endoscopic nasal and sinus polypectomy. STUDY
DESIGN: A prospective study of 24 patients with nasal and sinus polyps who were anosmic prior to endoscopic nasal and sinus surgery. Those who remained anosmic after surgery were treated with steroids. Most patients had asthma, allergic rhinitis, or both. A few had aspirin sensitivity.
METHODS: All 24 patients had testing of their sense of smell before and after surgery. Those who remained anosmic postoperatively were first treated with topical nasal and then oral steroids and then tested again.
RESULTS: Twelve of the 24 remained anosmic after surgery and were found to be unresponsive to nasal steroids, but oral steroids were found to restore the sense of smell to normal in most patients. Few patients continued to take the medication for long periods of time mainly because of a fear of side effects. Recent studies have suggested the role of systemic steroids in olfactory secretion, which may explain the mechanism for this response.
CONCLUSION: Patients who remain anosmic after the removal of nasal and sinus polyps can be treated with oral steroids resulting in improvement of their sense of smell. Further research is needed on a molecular level to determine the reason for this and also why oral but not nasal steroids are helpful in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11210860     DOI: 10.1097/00005537-200102000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  23 in total

1.  The role of TNF-α in inflammatory olfactory loss.

Authors:  Babar Sultan; Lindsey A May; Andrew P Lane
Journal:  Laryngoscope       Date:  2011-08-31       Impact factor: 3.325

2.  A genetic model of chronic rhinosinusitis-associated olfactory inflammation reveals reversible functional impairment and dramatic neuroepithelial reorganization.

Authors:  Andrew P Lane; Justin Turner; Lindsey May; Randall Reed
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

3.  Comparative effectiveness of medical and surgical therapy on olfaction in chronic rhinosinusitis: a prospective, multi-institutional study.

Authors:  Adam S DeConde; Jess C Mace; Jeremiah A Alt; Rodney J Schlosser; Timothy L Smith; Zachary M Soler
Journal:  Int Forum Allergy Rhinol       Date:  2014-07-12       Impact factor: 3.858

4.  Olfactory impairment in older adults: five-year incidence and risk factors.

Authors:  Carla R Schubert; Karen J Cruickshanks; Barbara E K Klein; Ronald Klein; David M Nondahl
Journal:  Laryngoscope       Date:  2011-02-04       Impact factor: 3.325

5.  Treatment of chronic rhinosinusitis with pressure-pulsed corticosteroid inhalation.

Authors:  Oender Goektas; Larissa Lau; Heidi Olze
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-02-15

Review 6.  Olfaction and anosmia in rhinosinusitis.

Authors:  Pamela Dalton
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

7.  Interferon gamma causes olfactory dysfunction without concomitant neuroepithelial damage.

Authors:  Tatyana Pozharskaya; Andrew P Lane
Journal:  Int Forum Allergy Rhinol       Date:  2013-09-17       Impact factor: 3.858

8.  Regulation of inflammation-associated olfactory neuronal death and regeneration by the type II tumor necrosis factor receptor.

Authors:  Tatyana Pozharskaya; Jonathan Liang; Andrew P Lane
Journal:  Int Forum Allergy Rhinol       Date:  2013-06-03       Impact factor: 3.858

9.  Olfactory loss in chronic rhinosinusitis is associated with neuronal activation of c-Jun N-terminal kinase.

Authors:  Andrew J Victores; Mengfei Chen; Amy Smith; Andrew P Lane
Journal:  Int Forum Allergy Rhinol       Date:  2017-11-28       Impact factor: 3.858

10.  Predictors of olfactory dysfunction in patients with chronic rhinosinusitis.

Authors:  Jamie R Litvack; Karen Fong; Jess Mace; Kenneth E James; Timothy L Smith
Journal:  Laryngoscope       Date:  2008-12       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.